Question

In: Statistics and Probability

To properly treat patients, drugs prescribed by physicians must have a potency that is accurately defined....

To properly treat patients, drugs prescribed by physicians must have a potency that is accurately defined. Consequently, not only must the distribution of potency values for shipments of a drug have a mean value as specified on the drug's container, but also the variation in potency must be small. Otherwise, pharmacists would be distributing drug prescriptions that could be harmfully potent or have a low potency and be ineffective. A drug manufacturer claims that its drug is marketed with a potency of 5 ± 0.1 milligram per cubic centimetre (mg/cc). A random sample of four containers gave potency readings equal to 4.93, 5.08, 5.03, and 4.89 mg/cc.

(a) Do the data present sufficient evidence to indicate that the mean potency differs from 5 mg/cc? (Use α = 0.05. Round your answers to three decimal places.)

1-2. Null and alternative hypotheses:

H0: μ = 5 versus Ha: μ < 5H0: μ ≠ 5 versus Ha: μ = 5    H0: μ = 5 versus Ha: μ > 5H0: μ < 5 versus Ha: μ > 5H0: μ = 5 versus Ha: μ ≠ 5


3. Test statistic:    t =  

4. Rejection region: If the test is one-tailed, enter NONE for the unused region.

t >
t <


5. Conclusion:

H0 is not rejected. There is insufficient evidence to indicate that the mean potency differs from 5 mg/cc.H0 is not rejected. There is sufficient evidence to indicate that the mean potency differs from 5 mg/cc.    H0 is rejected. There is sufficient evidence to indicate that the mean potency differs from 5 mg/cc.H0 is rejected. There is insufficient evidence to indicate that the mean potency differs from 5 mg/cc.


(b) Do the data present sufficient evidence to indicate that the variation in potency differs from the error limits specified by the manufacturer? (HINT: It is sometimes difficult to determine exactly what is meant by limits on potency as specified by a manufacturer. Since it implies that the potency values will fall into the interval 5.0 ± 0.1 mg/cc with very high probability—the implication is always—let us assume that the range 0.2; or (4.9 to 5.1), represents 6σ, as suggested by the Empirical Rule. Note that letting the range equal 6σ rather than 4σ places a stringent interpretation on the manufacturer's claim. We want the potency to fall into the interval

5.0 ± 0.1

with very high probability.) (Use α = 0.05. Round your answers to three decimal places.)

1-2. Null and alternative hypotheses:

H0: σ2 = 0.0011 versus Ha: σ2 < 0.0011H0: σ2 > 0.0011 versus Ha: σ2 < 0.0011    H0: σ2 = 0.2 versus Ha: σ2 ≠ 0.2H0: σ2 = 0.0011 versus Ha: σ2 > 0.0011H0: σ2 = 0.2 versus Ha: σ2 > 0.2


3. Test statistic:    χ2 =  

4. Rejection region: If the test is one-tailed, enter NONE for the unused region.

χ2 >
χ2 <


5. Conclusion:

H0 is rejected. There is insufficient evidence to indicate that the variation in potency differs from the specified error limits.H0 is rejected. There is sufficient evidence to indicate that the variation in potency differs from the specified error limits.    H0 is not rejected. There is insufficient evidence to indicate that the variation in potency differs from the specified error limits.H0 is not rejected. There is sufficient evidence to indicate that the variation in potency differs from the specified error limits.

Solutions

Expert Solution

a.
Given that,
population mean(u)=5
sample mean, x =4.9825
standard deviation, s =0.0877
number (n)=4
null, Ho: μ=5
alternate, H1: μ!=5
level of significance, α = 0.05
from standard normal table, two tailed t α/2 =3.182
since our test is two-tailed
reject Ho, if to < -3.182 OR if to > 3.182
we use test statistic (t) = x-u/(s.d/sqrt(n))
to =4.9825-5/(0.0877/sqrt(4))
to =-0.399
| to | =0.399
critical value
the value of |t α| with n-1 = 3 d.f is 3.182
we got |to| =0.399 & | t α | =3.182
make decision
hence value of |to | < | t α | and here we do not reject Ho
p-value :two tailed ( double the one tail ) - Ha : ( p != -0.3991 ) = 0.7165
hence value of p0.05 < 0.7165,here we do not reject Ho
ANSWERS
---------------
1.
null, Ho: μ=5
2.
alternate, H1: μ!=5
3.
test statistic: -0.399
critical value: -3.182 , 3.182
4.
test two tailed
decision: do not reject Ho
p-value: 0.7165
5.
we do not have enough evidence to indicate that the mean potency differs from 5 mg/cc

b.
Given that,
population variance (σ^2) =0.0011
sample size (n) = 4
sample variance (s^2)=0.00769
null, Ho: σ^2 =0.0011
alternate, H1 : σ^2 !=0.0011
level of significance, α = 0.05
from standard normal table, two tailed ᴪ^2 α/2 =7.815
since our test is two-tailed
reject Ho, if ᴪ^2 o < - OR if ᴪ^2 o > 7.815
we use test statistic chisquare ᴪ^2 =(n-1)*s^2/o^2
ᴪ^2 cal=(4 - 1 ) * 0.00769 / 0.0011 = 3*0.00769/0.0011 = 20.973
| ᴪ^2 cal | =20.973
critical value
the value of |ᴪ^2 α| at los 0.05 with d.f (n-1)=3 is 7.815
we got | ᴪ^2| =20.973 & | ᴪ^2 α | =7.815
make decision
hence value of | ᴪ^2 cal | > | ᴪ^2 α| and here we reject Ho
ᴪ^2 p_value =0.0001
ANSWERS
---------------
1.
null, Ho: σ^2 =0.0011
2.
alternate, H1 : σ^2 !=0.0011
3.
test statistic: 20.973
critical value: -7.815 , 7.815
p-value:0.0001
4.
test two tailed
decision: reject Ho
5.
we have enough evidence to indicate that the variation in potency differs from the specified error limits


Related Solutions

Explain the ways in which the drugs prescribed to treat depression, schizophrenia, and anxiety work.
Explain the ways in which the drugs prescribed to treat depression, schizophrenia, and anxiety work.
Physicians at a clinic gave what they thought were drugs to 800 patients. The doctors later...
Physicians at a clinic gave what they thought were drugs to 800 patients. The doctors later learned that the drugs were really placebos. 53% of the patients reported an improved condition even though they weren't actually taking a drug. It is known that without a taking drug the probability of a patient's condition improving is 0.49. Test the hypothesis that the proportion of patients improving after taking a placebo is greater than 0.49. (a) State the null and alternative hypotheses....
Is the common - law position that physicians have no general duty to treat morally acceptable??...
Is the common - law position that physicians have no general duty to treat morally acceptable?? In your answer,, be sure to appeal to at least two moral theories..   
When veterinarians working in zoos treat animals with drugs they must take metabolic rate allometry into...
When veterinarians working in zoos treat animals with drugs they must take metabolic rate allometry into account in designing dosage regimes in order not to overdose larger animals. This is a practical application of the information we have about how body mass relates to the rates of cellular activities. What changes occur with respect to the abundance in mammalian cells of 'metabolic machinery' like mitochondria, key proteins, and key processes as we go from the cells of small species like...
1. Why do drugs not have the same effect on all patients?
1. Why do drugs not have the same effect on all patients?
You have discovered that one of your physicians is violating the Stark law by sending patients...
You have discovered that one of your physicians is violating the Stark law by sending patients to an imaging center in which she has an ownership percentage. She offers you a monthly consulting fee if you don’t say anything and let her continue to refer patients. She tells you that the facility is good and the patients are not being harmed. a. Explain what the Stark law is. b. Discuss what you would do in this situation. c. What consequences...
Workflows are horizontal tasks that must be accomplished to have the system function properly. True False...
Workflows are horizontal tasks that must be accomplished to have the system function properly. True False I have no clue (not the best response, yet it might be true) Project management is a process that allows what to occur? Effective use of materials Control of limited resources Organization of all available resources over time Efficient use of resources Control and organization especially around change management processes All of the above None of the above Where did you get all this...
1) How can convalescent serum from patients who have recovered from COVID-19 be used to treat...
1) How can convalescent serum from patients who have recovered from COVID-19 be used to treat sick patients? What part of the serum might be beneficial to these patients? 2) I saw a report this week that the mutation rate for SARS-CoV-2 is much less than that of the influenza virus. How does this information impact the efficacy of any new vaccine? 3) Besides vaccination, what other therapies are being developed/tested? What do these therapies target in the virus?
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT